Catalyst Pharma (CPRX)
NASDAQ:CPRX
Holding CPRX?
Track your performance easily

Catalyst Pharma (CPRX) Cash flow

2,100 Followers

Catalyst Pharma Cash Flow

CPRX's free cash flow for Q3 2024 was $72.61M. For the 2024 fiscal year, CPRX's free cash flow was decreased by $27.35M and operating cash flow was $72.87M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 224.58M$ 143.60M$ 116.05M$ 60.37M$ 45.03M$ 34.61M
Investing Cash Flow
$ -38.79M$ -293.50M$ 9.21M$ -11.02M$ -5.01M$ 37.22M
Financing Cash Flow
$ 135.57M$ -10.86M$ 1.69M$ -8.14M$ 702.00K$ 1.12M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 1.27B$ 137.64M$ 298.39M$ 171.44M$ 89.51M$ 89.51M
Income Tax Paid Supplemental Data
$ 60.49M$ 50.46M$ 7.67M$ 3.00M$ 2.79M-
Interest Paid Supplemental Data
$ 1.36M$ 705.00K----
Issuance Of Capital Stock
$ 141.00M-----
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ 221.79M$ 143.37M$ 116.02M$ 59.35M$ 45.02M$ 34.59M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Catalyst Pharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis